Vasomedical Gains CHF Indication For Noninvasive Counterpulsation Therapy

A new congestive heart failure indication could create a 10-fold increase in the number of patients eligible for Vasomedical's EECP counterpulsation therapy system

More from Archive

More from Medtech Insight